Posted in | News | Mining Business

Olivut Provides Update on Funding and Exploration

Olivut Resources Ltd. is pleased to provide a funding and exploration update.

Continued financial support is being provided by the Canadian Special Opportunity Fund, L.P.. The terms of the Securities Purchase Agreement dated March 12, 2013, between CSOF and Olivut provide the flexibility to alter tranche financing based on cash flow requirements and current market conditions. Consequently, in order to avoid unnecessary dilution at current stock prices Olivut has requested a reduction in funding at this time and accordingly, pursuant to the terms of the Agreement, CSOF has advanced to the Company $42,500 for the next tranche financing for which it is anticipated shares will be issued on September 15, 2014. CSOF was issued 290,909 shares of the Company on June 17, 2014 at $0.165 per share as repayment for the $48,000 tranche funding received on May 2, 2014.

Exploration on the HOAM Project is comprised predominantly of an ongoing interpretation of the Company's extensive regional airborne geophysical database. This work is nearing completion. Additional new targets have been defined up ice from high interest kimberlite indicator mineral (KIM) populations. Bedrock sources for these KIMs have not been identified by previous work. Detailed airborne magnetic surveys will be carried out over the new targets and it is anticipated that many will be added to the list of priority targets slated to be tested by the next stage of drilling. Some detailed airborne work is scheduled for the remaining 2014 field season as funding and weather (including forest fire) conditions permit.

The ongoing geophysical analysis combined with the proposed detailed airborne survey work will define new priority drill targets and could place the Company in a strong position if market sentiment improves and junior exploration drilling programs are actively supported. Given world market atmosphere for equity financing of junior companies, Management believes it is in the shareholders' best interest for the Company to maintain a conservative approach to exploration while continuing to advance its field projects.

Additional information on the Company, including copies of the qualifying base shelf prospectus dated March 11, 2013, the prospectus supplement dated March 12, 2013 and specific Pricing Supplements for securities issued, are available on SEDAR. These documents, as well as any documents incorporated therein by reference may be obtained on request without charge from Olivut, at its offices located at 27010 Highway 16, 14 Mountain Park Properties, Jasper East, Alberta, or by faxing a written request to (780) 866-3713, by mail to P.O. Box 6690 Hinton, Alberta T7V 1X8 or by accessing the disclosure documents available through the internet on the Canadian System for Electronic Document Analysis and Retrieval (SEDAR) website at www.sedar.com. Unless provided otherwise in a pricing supplement, the following is a description of a purchaser's statutory rights:

Securities legislation in certain of the provinces of Canada provides purchasers with the right to withdraw from an agreement to purchase securities. This right may be exercised within two business days after receipt or deemed receipt of a prospectus and any amendment. In several of the provinces, the securities legislation further provides a purchaser with remedies for rescission or, in some jurisdictions, revision of the price or damages if the prospectus and any amendment are not delivered to the purchaser, provided that the remedies for rescission, revisions of the price or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser's province. However, such rights and remedies will not be available to purchasers of common shares distributed under the prospectus supplement because the prospectus, the prospectus supplement and the relevant pricing supplement will not be delivered to purchasers, as permitted under a decision document issued by the Alberta Securities Commission on December 5, 2012. The securities legislation further provides a purchaser with remedies for recession or, in some jurisdictions, revisions of the price or damages, if the prospectus and any amendment contain a misrepresentation, provided that the remedies for recession, revisions of the price or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser's province. Such remedies remain unaffected by the non-delivery of the prospectus permitted under the decision documents referred to above. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser's province for the particulars of these rights or consult with a legal adviser.

Source: http://www.olivut.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Olivut Resources Ltd. (2019, March 19). Olivut Provides Update on Funding and Exploration. AZoMining. Retrieved on April 19, 2024 from https://www.azomining.com/News.aspx?newsID=10347.

  • MLA

    Olivut Resources Ltd. "Olivut Provides Update on Funding and Exploration". AZoMining. 19 April 2024. <https://www.azomining.com/News.aspx?newsID=10347>.

  • Chicago

    Olivut Resources Ltd. "Olivut Provides Update on Funding and Exploration". AZoMining. https://www.azomining.com/News.aspx?newsID=10347. (accessed April 19, 2024).

  • Harvard

    Olivut Resources Ltd. 2019. Olivut Provides Update on Funding and Exploration. AZoMining, viewed 19 April 2024, https://www.azomining.com/News.aspx?newsID=10347.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.